Serotonergic Neurons (secretion) < Serotonin < Serotonin (analysis)

Facettes :

List of bibliographic references indexed by Serotonin

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]

Ident.	Authors (with country if any)	Title
000B10 (2014)	Sylvia Navailles [France] ; Lea Milan [France] ; Hanane Khalki [France] ; Giuseppe Di Giovanni [Royaume-Uni, Malte] ; Mélanie Lagiere [France] ; Philippe De Deurwaerdere [France]	Noradrenergic Terminals Regulate L-DOPA-derived Dopamine Extracellular Levels in a Region-dependent Manner in Parkinsonian Rats
000F46 (2013)	M. Lagière [France] ; S. Navailles [France] ; L. Mignon [États-Unis] ; A. Roumegous [France] ; M.-F. Chesselet [États-Unis] ; P. De Deurwaerdère [France]	The enhanced oral response to the 5-HT2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: electrophysiological correlates
001225 (2012)	Benedicte Ballanger [France] ; Helene Klinger [France] ; Julien Eche [France] ; Jérôme Lerond [France] ; Anne-Evelyne Vallet [France] ; Didier Le Bars [France] ; Leon Tremblay [France] ; Véronique Sgambato-Faure [France] ; Emmanuel Broussolle [France] ; Stéphane Thobois [France]	Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease
001389 (2012)	P. De Deurwaerdere [France] ; S. Navailles [France]	What can we expect from the serotonergic side of L-DOPA?
001429 (2012)	C. Delaville [France] ; S. Navailles [France] ; A. Benazzouz [France]	EFFECTS OF NORADRENALINE AND SEROTONIN DEPLETIONS ON THE NEURONAL ACTIVITY OF GLOBUS PALLIDUS AND SUBSTANTIA NIGRA PARS RETICULATA IN EXPERIMENTAL PARKINSONISM
001816 (2011)	Sylvia Navailles [France] ; Philippe De Deurwaerdere [France]	Presynaptic control of serotonin on striatal dopamine function
001853 (2011)	M. Carta [Suède, Italie] ; E. Bezard [France]	CONTRIBUTION OF PRE-SYNAPTIC MECHANISMS TO L-DOPA-INDUCED DYSKINESIA
001B72 (2010)	Daniella Rylander [Suède] ; Martin Parent [Canada] ; Sean S. O'Sullivan [Royaume-Uni] ; Sandra Dovero [France] ; Andrew J. Lees [Royaume-Uni] ; Erwan Bezard [France] ; Laurent Descarries [Canada] ; M. Angela Cenci [Suède]	Maladaptive plasticity of serotonin axon terminals in levodopa‐induced dyskinesia
001C88 (2010)	D. Devos [France] ; R. Bordet [France] ; L. Defebvre [France]	Hypothèses pharmacologiques et prise en charge thérapeutique des troubles de la marche de la maladie de Parkinson : Troubles de la marche
001D36 (2010)	Dawn M. Eagle [Royaume-Uni] ; Christelle Baunez [France]	Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition
002413 (2008)	David Devos [France] ; Kathy Dujardin [France] ; Isabelle Poirot [France] ; Caroline Moreau [France] ; Olivier Cottencin [France] ; Pierre Thomas [France] ; Alain Destée [France] ; Regis Bordet [France] ; Luc Defebvre [France]	Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study
002790 (2007)	Charlotte Laloux [France] ; Philippe Derambure [France] ; Jean-Marie Jacquesson [France] ; Régis Bordet [France] ; Alain Destée [France] ; Christelle Monaca [France]	The effects of serotoninergic, noradrenergic, cholinergic and dopaminergic drugs on vigilance states in MPTP-treated mice
003230 (2003)	Mireille Gony [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France]	Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: A pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs
003249 (2003)	Larissa Takser [France] ; Donna Mergler [Canada] ; Georgette Hellier [France] ; Josiane Sahuquillo [France] ; Guy Huel [France]	Manganese, monoamine metabolite levels at birth, and child psychomotor development
003410 (2002)	P. Pollak [France]	Troubles psychiques
003439 (2002)	André Galinowski [France] ; Marie-Laure Paillere-Martinot [France]	La stimulation magnétique transcrânienne répétée : Vers un nouvel outil thérapeutique en psychiatrie : Les avancées scientifiques en psychiatrie
003B80 (2000)	A.-M. Bonnet [France]	Involvement of non-dopaminergic pathways in Parkinson's disease : Pathophysiology and therapeutic implications
003C24 (1999-12)		ETUDE DES CARACTERISTIQUES PHARMACOLOGIQUES ET DU RÔLE DES AUTO ET DES HETERORECEPTEURS 5-HT1B DANS LE CONTRÔLE DE L'ACTIVITE DOPAMINERGIQUE DU STRIATUM
004157 (1998)	J. L. Montastruc [France] ; M. Pelat [France] ; P. Verwaerde [France] ; C. Brefel-Courbon [France] ; M. A. Tran [France] ; O. Blin [France] ; O. Rascol [France] ; J. M. Senard [France]	Fluoxetine in orthostatic hypotension of Parkinson's disease : A clinical and experimental pilot study
004460 (1996-12)		Un organe de contrôle inspiré de la neuromodulation pour les Réseaux à Propagation Guidée
004876 (1995)	F. Thibaut [France] ; B. A. Faucheux [France] ; J. Marquez [France] ; J. Villares [France] ; J. F. Menard [France] ; Yves Agid [France] ; E. C. Hirsch [France]	Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease : a postmortem study using tritiated tetrabenazine

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Serotonin" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Serotonin" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Serotonin
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024